Trials / Conditions / Pantothenate Kinase-Associated Neurodegeneration
Pantothenate Kinase-Associated Neurodegeneration
5 registered clinical trials studyying Pantothenate Kinase-Associated Neurodegeneration.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | CoA-Z in Pantothenate Kinase-associated Neurodegeneration (PKAN) NCT04182763 | Oregon Health and Science University | N/A |
| Terminated | Efficacy and Safety Study of Fosmetpantotenate (RE-024) in PKAN Participants NCT03041116 | Travere Therapeutics, Inc. | Phase 3 |
| Completed | Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration NCT02174848 | ApoPharma | Phase 3 |
| Completed | Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PK NCT01741532 | ApoPharma | Phase 3 |
| No Longer Available | Compassionate Use of Deferiprone in Patients With PKAN NCT02635841 | Chiesi Canada Corp | — |